What is Azenta Inc's earnings per share (EPS)?

Azenta Inc (AZTA) reported diluted earnings per share of $-1.22 for fiscal year 2025. This represents a 60.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Azenta Inc Financials

AZTA

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE September

This page shows Azenta Inc (AZTA) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI AZTA FY2025 2026-05-08

Azenta’s cash generation is recovering faster than earnings as flat overhead and leaner working capital support liquidity.

Over the last two fiscal years, free cash flow moved from -$33.6M to $38.3M even though net income stayed negative. Operating losses narrowed while inventory and receivables shrank together, which indicates the improvement came from both better cost absorption and less cash being trapped in day-to-day operations.

Revenue rose only modestly, but gross margin reached 45.5% and SG&A stayed roughly flat in dollars, so more of each sales dollar was available to cover fixed costs. Operating margin improved from -11.1% to -4.5%, a sign of expense discipline rather than a dramatic change in sales volume.

With $279.8M of cash, a current ratio of 3.0x, and no long-term debt reported, the balance sheet still provides room to absorb uneven earnings. The lower cash balance versus FY2023 reads less like operating strain and more like the aftereffect of earlier share repurchases, which consumed cash without adding leverage.

Financial Health Signals

Financial Profile 39/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Azenta Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Azenta Inc has an operating margin of -4.5%, meaning the company retains $-5 of operating profit per $100 of revenue. This below-average margin results in a low score of 6/100, suggesting thin profitability after operating expenses. This is up from -8.9% the prior year.

Growth

Azenta Inc's revenue grew a modest 3.6% year-over-year to $593.8M. This slow but positive growth earns a score of 40/100.

Leverage

Azenta Inc carries a low D/E ratio of 0.19, meaning only $0.19 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 98/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Azenta Inc's current ratio of 2.98 indicates adequate short-term liquidity, earning a score of 57/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Azenta Inc has a free cash flow margin of 6.5%, earning a moderate score of 32/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Azenta Inc generates a -3.2% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 1/100. This is up from -9.3% the prior year.

Piotroski F-Score Neutral

5/9

Azenta Inc passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Mixed

-1.29x

For every $1 of reported earnings, Azenta Inc generates $-1.29 in operating cash flow ($72.2M OCF vs -$55.8M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$593.8M

YoY+3.6%

5Y CAGR+8.9%

10Y CAGR+0.7%

Azenta Inc generated $593.8M in revenue in fiscal year 2025. This represents an increase of 3.6% from the prior year.

EBITDA

$34.4M

YoY-12.9%

5Y CAGR+3.5%

10Y CAGR-2.0%

Azenta Inc's EBITDA was $34.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 12.9% from the prior year.

Net Income

-$55.8M

YoY+66.2%

Azenta Inc reported -$55.8M in net income in fiscal year 2025. This represents an increase of 66.2% from the prior year.

EPS (Diluted)

$-1.22

YoY+60.6%

Azenta Inc earned $-1.22 per diluted share (EPS) in fiscal year 2025. This represents an increase of 60.6% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$38.3M

YoY+210.3%

10Y CAGR+3.3%

Azenta Inc generated $38.3M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 210.3% from the prior year.

Cash & Debt

$279.8M

YoY-0.1%

5Y CAGR+2.2%

10Y CAGR+13.2%

Azenta Inc held $279.8M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

46M

YoY+0.6%

5Y CAGR-9.1%

10Y CAGR-3.8%

Azenta Inc had 46M shares outstanding in fiscal year 2025. This represents an increase of 0.6% from the prior year.

Margins & Returns

Gross Margin

45.5%

YoY+1.1pp

5Y CAGR+1.2pp

10Y CAGR+11.3pp

Azenta Inc's gross margin was 45.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 1.1 percentage points from the prior year.

Operating Margin

-4.5%

YoY+4.4pp

5Y CAGR+4.9pp

10Y CAGR-7.6pp

Azenta Inc's operating margin was -4.5% in fiscal year 2025, reflecting core business profitability. This is up 4.4 percentage points from the prior year.

Net Margin

-9.4%

YoY+19.4pp

5Y CAGR-26.1pp

10Y CAGR-12.0pp

Azenta Inc's net profit margin was -9.4% in fiscal year 2025, showing the share of revenue converted to profit. This is up 19.4 percentage points from the prior year.

Return on Equity

-3.2%

YoY+6.1pp

5Y CAGR-8.6pp

10Y CAGR-5.5pp

Azenta Inc's ROE was -3.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 6.1 percentage points from the prior year.

Capital Allocation

R&D Spending

$30.4M

YoY-3.6%

5Y CAGR+11.3%

10Y CAGR-5.3%

Azenta Inc invested $30.4M in research and development in fiscal year 2025. This represents a decrease of 3.6% from the prior year.

Share Buybacks

YoY-100.0%

Azenta Inc spent $0 on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 100.0% from the prior year.

Capital Expenditures

$33.9M

YoY-9.5%

5Y CAGR-3.2%

10Y CAGR+7.7%

Azenta Inc invested $33.9M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 9.5% from the prior year.

AZTA Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$593.8M+3.6%	$573.4M+4.0%	$551.5M-0.7%	$555.5M+8.1%	$513.7M+32.2%	$388.5M
Cost of Revenue	$323.5M+1.5%	$318.8M+2.1%	$312.3M+4.1%	$299.9M+11.1%	$269.9M+24.7%	$216.4M
Gross Profit	$270.3M+6.1%	$254.6M+6.4%	$239.2M-6.4%	$255.6M+4.8%	$243.8M+41.6%	$172.1M
R&D Expenses	$30.4M-3.6%	$31.5M-1.9%	$32.1M+16.7%	$27.5M+22.9%	$22.4M+25.8%	$17.8M
SG&A Expenses	$261.6M-0.5%	$263.0M-0.3%	$263.7M+4.9%	$251.5M-0.3%	$252.1M+32.5%	$190.3M
Operating Income	-$26.8M+47.7%	-$51.3M+16.3%	-$61.2M-147.6%	-$24.7M+20.4%	-$31.1M+15.1%	-$36.6M
Interest Expense	N/A	N/A	N/A	$4.6M+125.3%	$2.0M-30.8%	$2.9M
Income Tax	-$31.6M-703.0%	$5.2M+143.8%	-$12.0M-986.3%	$1.4M+106.7%	-$20.1M-44.3%	-$13.9M
Net Income	-$55.8M+66.2%	-$164.9M-1026.7%	-$14.6M-100.7%	$2.1B+1825.9%	$110.7M+70.8%	$64.9M
EPS (Diluted)	$-1.22+60.6%	$-3.10-1309.1%	$-0.22-100.8%	$28.48+1811.4%	$1.49+69.3%	$0.88

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$144.8M-2.6%	$148.6M-6.6%	$159.2M+10.7%	$143.9M+0.4%	$143.3M-2.8%	$147.4M-2.1%	$150.6M+4.4%	$144.3M
Cost of Revenue	$82.8M-2.6%	$84.9M-2.3%	$86.9M+12.2%	$77.5M-3.9%	$80.6M+2.5%	$78.6M-4.3%	$82.1M+3.0%	$79.7M
Gross Profit	$62.0M-2.6%	$63.7M-11.9%	$72.3M+8.8%	$66.4M+5.8%	$62.8M-8.8%	$68.8M+0.5%	$68.5M+6.0%	$64.6M
R&D Expenses	$9.4M+2.7%	$9.2M+11.3%	$8.3M+11.3%	$7.4M-2.4%	$7.6M+6.9%	$7.1M-5.7%	$7.5M-0.6%	$7.6M
SG&A Expenses	$67.9M+12.0%	$60.6M-1.8%	$61.7M+2.7%	$60.1M-13.9%	$69.8M-0.3%	$70.0M+8.1%	$64.7M+3.7%	$62.4M
Operating Income	-$165.8M-2190.9%	-$7.2M-480.7%	$1.9M+202.8%	-$1.9M+89.8%	-$18.2M-109.1%	-$8.7M-87.6%	-$4.6M+34.7%	-$7.1M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	-$323K-110.3%	$3.1M+106.9%	-$45.4M-1821.2%	$2.6M-63.6%	$7.2M+87.0%	$3.9M+90.3%	$2.0M+255.3%	$573K
Net Income	-$160.8M-942.0%	-$15.4M-130.3%	$50.9M+206.0%	-$48.0M-0.7%	-$47.7M-333.6%	-$11.0M-65.6%	-$6.6M-1.3%	-$6.6M
EPS (Diluted)	$-3.49-926.5%	$-0.34-130.6%	$1.11+205.7%	$-1.05-1.0%	$-1.04-316.0%	$-0.25-78.6%	$-0.14-16.7%	$-0.12

AZTA Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$2.1B-1.9%	$2.1B-27.2%	$2.9B-22.4%	$3.7B+104.2%	$1.8B+16.7%	$1.6B
Current Assets	$708.3M-15.0%	$833.0M-41.3%	$1.4B-42.3%	$2.5B+216.4%	$777.4M+19.7%	$649.5M
Cash & Equivalents	$279.8M-0.1%	$280.0M-56.9%	$649.5M-1.3%	$658.3M+189.4%	$227.4M-9.3%	$250.6M
Inventory	$75.0M+5.1%	$71.3M-44.4%	$128.2M+49.9%	$85.5M+41.6%	$60.4M+62.7%	$37.1M
Accounts Receivable	$142.2M-7.8%	$154.2M-1.5%	$156.5M-4.4%	$163.8M+36.6%	$119.9M+26.5%	$94.8M
Goodwill	$702.4M+1.6%	$691.4M+2.4%	$675.4M+31.5%	$513.6M+9.4%	$469.4M+3.6%	$453.2M
Total Liabilities	$332.6M+0.1%	$332.4M-5.4%	$351.2M-0.4%	$352.7M-28.6%	$494.2M+43.0%	$345.7M
Current Liabilities	$237.7M+15.3%	$206.1M-2.3%	$210.9M-8.5%	$230.5M-33.2%	$345.1M+63.5%	$211.1M
Long-Term Debt	N/A	N/A	N/A	N/A	$49.7M+0.2%	$49.6M
Total Equity	$1.7B-2.3%	$1.8B-30.2%	$2.5B-24.7%	$3.4B+153.8%	$1.3B+9.2%	$1.2B
Retained Earnings	$1.4B-3.8%	$1.5B-10.1%	$1.6B-0.9%	$1.7B+452.2%	-$470.1M+14.7%	-$551.1M

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$1.9B-8.2%	$2.1B+0.7%	$2.1B+2.0%	$2.0B-0.7%	$2.0B-0.4%	$2.0B-2.7%	$2.1B-9.6%	$2.3B
Current Assets	$727.0M-6.8%	$779.9M+10.1%	$708.3M+4.4%	$678.3M-4.5%	$710.4M-16.2%	$847.8M+1.8%	$833.0M-13.9%	$967.7M
Cash & Equivalents	$234.0M-30.5%	$336.6M+20.3%	$279.8M+3.6%	$270.0M+6.5%	$253.6M-32.8%	$377.5M+34.8%	$280.0M-16.8%	$336.5M
Inventory	$78.5M-4.8%	$82.5M+10.0%	$75.0M-7.3%	$80.8M+7.6%	$75.2M+0.2%	$75.0M+5.1%	$71.3M-38.1%	$115.3M
Accounts Receivable	$131.3M-7.7%	$142.3M+0.1%	$142.2M+14.2%	$124.5M-15.2%	$146.9M-3.5%	$152.3M-1.2%	$154.2M-8.0%	$167.6M
Goodwill	$553.1M-21.3%	$702.6M0.0%	$702.4M-0.2%	$703.6M+3.0%	$683.0M+1.5%	$672.9M-2.7%	$691.4M+1.7%	$679.7M
Total Liabilities	$349.2M-2.9%	$359.6M+8.1%	$332.6M-3.9%	$346.0M+2.2%	$338.6M+4.9%	$322.6M-3.0%	$332.4M-0.1%	$332.9M
Current Liabilities	$257.2M-3.8%	$267.2M+12.4%	$237.7M-3.5%	$246.2M+11.4%	$221.0M+9.1%	$202.5M-1.7%	$206.1M+1.7%	$202.6M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$1.6B-9.3%	$1.7B-0.7%	$1.7B+3.2%	$1.7B-1.3%	$1.7B-1.4%	$1.7B-2.7%	$1.8B-11.2%	$2.0B
Retained Earnings	$1.2B-11.4%	$1.4B-1.1%	$1.4B+3.7%	$1.4B-3.4%	$1.4B-3.3%	$1.5B-0.7%	$1.5B-0.4%	$1.5B

AZTA Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$72.2M+45.1%	$49.7M+752.6%	$5.8M+101.3%	-$466.0M-411.0%	$149.9M+295.8%	$37.9M
Capital Expenditures	$33.9M-9.5%	$37.4M-5.2%	$39.4M-46.3%	$73.4M+39.1%	$52.8M+32.3%	$39.9M
Free Cash Flow	$38.3M+210.3%	$12.4M+136.8%	-$33.6M+93.8%	-$539.5M-655.9%	$97.1M+4815.8%	-$2.1M
Investing Cash Flow	-$90.5M-140.3%	$224.7M-47.9%	$431.4M-70.6%	$1.5B+1101.4%	-$146.3M-543.5%	-$22.7M
Financing Cash Flow	-$9.6M+98.5%	-$659.2M+21.6%	-$840.5M-1239.1%	-$62.8M-142.3%	-$25.9M+4.1%	-$27.0M
Dividends Paid	N/A	$0	$0-100.0%	$7.5M-74.8%	$29.7M+0.7%	$29.5M
Share Buybacks	$0-100.0%	$661.7M-21.1%	$838.5M	$0	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	$13.5M-35.2%	$20.8M+860.7%	$2.2M-91.6%	$25.8M+79.2%	$14.4M-51.7%	$29.8M+68.6%	$17.7M+80.8%	$9.8M
Capital Expenditures	$7.4M+19.6%	$6.2M-21.2%	$7.9M-27.5%	$10.8M+46.3%	$7.4M-4.4%	$7.8M-17.4%	$9.4M+10.7%	$8.5M
Free Cash Flow	$6.1M-58.3%	$14.7M+357.6%	-$5.7M-138.0%	$15.0M+114.0%	$7.0M-68.3%	$22.0M+165.8%	$8.3M+537.1%	$1.3M
Investing Cash Flow	-$114.7M-412.1%	$36.8M+4351.8%	$826K+102.8%	-$29.7M+78.6%	-$138.7M-279.9%	$77.1M-61.1%	$198.0M-0.9%	$199.7M
Financing Cash Flow	$980K+137.2%	-$2.6M-422.2%	$817K+738.3%	-$128K+97.5%	-$5.2M-0.5%	-$5.1M+97.9%	-$247.5M-9.5%	-$226.1M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	$0	$0	$0	$0-100.0%	$248.9M+10.2%	$225.9M

AZTA Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	45.5%+1.1pp	44.4%+1.0pp	43.4%-2.6pp	46.0%-1.5pp	47.5%+3.2pp	44.3%
Operating Margin	-4.5%+4.4pp	-8.9%+2.2pp	-11.1%-6.7pp	-4.5%+1.6pp	-6.0%+3.4pp	-9.4%
Net Margin	-9.4%+19.4pp	-28.8%-26.1pp	-2.6%-386.6pp	383.9%+362.4pp	21.6%+4.9pp	16.7%
Return on Equity	-3.2%+6.1pp	-9.3%-8.8pp	-0.6%-64.0pp	63.4%+55.0pp	8.4%+3.0pp	5.3%
Return on Assets	-2.7%+5.1pp	-7.8%-7.3pp	-0.5%-57.9pp	57.4%+51.3pp	6.1%+1.9pp	4.2%
Current Ratio	2.98-1.1	4.04-2.7	6.73-3.9	10.67+8.4	2.25-0.8	3.08
Debt-to-Equity	0.190.0	0.19+0.0	0.14+0.0	0.10+0.1	0.040.0	0.04
FCF Margin	6.5%+4.3pp	2.1%+8.2pp	-6.1%+91.0pp	-97.1%-116.0pp	18.9%+19.4pp	-0.5%

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	42.8%-0.0pp	42.9%-2.5pp	45.4%-0.8pp	46.2%+2.4pp	43.8%-2.9pp	46.7%+1.2pp	45.5%+0.7pp	44.8%
Operating Margin	-114.5%-109.6pp	-4.9%-6.1pp	1.2%+2.5pp	-1.3%+11.4pp	-12.7%-6.8pp	-5.9%-2.8pp	-3.1%+1.8pp	-4.9%
Net Margin	-111.1%-100.7pp	-10.4%-42.3pp	32.0%+65.3pp	-33.4%-0.1pp	-33.3%-25.8pp	-7.5%-3.0pp	-4.4%+0.1pp	-4.5%
Return on Equity	-10.3%-9.4pp	-0.9%-3.9pp	2.9%+5.8pp	-2.9%-0.1pp	-2.8%-2.2pp	-0.6%-0.3pp	-0.4%-0.1pp	-0.3%
Return on Assets	-8.5%-7.7pp	-0.7%-3.2pp	2.5%+4.9pp	-2.4%-0.0pp	-2.3%-1.8pp	-0.5%-0.2pp	-0.3%-0.0pp	-0.3%
Current Ratio	2.83-0.1	2.92-0.1	2.98+0.2	2.76-0.5	3.21-1.0	4.19+0.1	4.04-0.7	4.78
Debt-to-Equity	0.22+0.0	0.21+0.0	0.19-0.0	0.210.0	0.20+0.0	0.190.0	0.19+0.0	0.17
FCF Margin	4.2%-5.6pp	9.9%+13.4pp	-3.6%-14.0pp	10.4%+5.5pp	4.9%-10.1pp	14.9%+9.4pp	5.5%+4.6pp	0.9%

Similar Companies

Staar Surg STAA

$1.6B

Biolife Solutions Inc BLFS

$1.2B

Atricure ATRC

$1.5B

ANBIO BIOTECHNOLOGY NNNN

$1.3B

Pulse Biosciences Inc PLSE

$1.8B

Frequently Asked Questions

What is Azenta Inc's annual revenue?

Azenta Inc (AZTA) reported $593.8M in total revenue for fiscal year 2025. This represents a 3.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Azenta Inc's revenue growing?

Azenta Inc (AZTA) revenue grew by 3.6% year-over-year, from $573.4M to $593.8M in fiscal year 2025.

Is Azenta Inc profitable?

No, Azenta Inc (AZTA) reported a net income of -$55.8M in fiscal year 2025, with a net profit margin of -9.4%.

What is Azenta Inc's EBITDA?

Azenta Inc (AZTA) had EBITDA of $34.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Azenta Inc's gross margin?

Azenta Inc (AZTA) had a gross margin of 45.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Azenta Inc's operating margin?

Azenta Inc (AZTA) had an operating margin of -4.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Azenta Inc's net profit margin?

Azenta Inc (AZTA) had a net profit margin of -9.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Azenta Inc's return on equity (ROE)?

Azenta Inc (AZTA) has a return on equity of -3.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Azenta Inc's free cash flow?

Azenta Inc (AZTA) generated $38.3M in free cash flow during fiscal year 2025. This represents a 210.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Azenta Inc's operating cash flow?

Azenta Inc (AZTA) generated $72.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Azenta Inc's total assets?

Azenta Inc (AZTA) had $2.1B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Azenta Inc's capital expenditures?

Azenta Inc (AZTA) invested $33.9M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Azenta Inc spend on research and development?

Azenta Inc (AZTA) invested $30.4M in research and development during fiscal year 2025.

How many shares does Azenta Inc have outstanding?

Azenta Inc (AZTA) had 46M shares outstanding as of fiscal year 2025.

What is Azenta Inc's current ratio?

Azenta Inc (AZTA) had a current ratio of 2.98 as of fiscal year 2025, which is generally considered healthy.

What is Azenta Inc's debt-to-equity ratio?

Azenta Inc (AZTA) had a debt-to-equity ratio of 0.19 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Azenta Inc's return on assets (ROA)?

Azenta Inc (AZTA) had a return on assets of -2.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Azenta Inc's Piotroski F-Score?

Azenta Inc (AZTA) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Azenta Inc's earnings high quality?

Azenta Inc (AZTA) has an earnings quality ratio of -1.29x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Azenta Inc?

Azenta Inc (AZTA) scores 39 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.